‘Our research provides the first evidence meninges, the system of membranes that cover the surface of the brain and spinal cord, stem cells renew able themselves and proliferation are contains, ‘said lead author Dr Ilaria Decimo and Dr Francesco Bifari, at the University of Verona – proliferate by a spinal injury meningeal cells and migrate in glial scars and the team make believe this process explains part of the mechanism of stem cell activation in central nervous system, a mechanism that. Could be reused for the treatment Dr Decimo team showed microdissected samples of spinal cord meninges from adult rats that meningeal cells contain crucial stem cell properties are those properties which increase following a spinal cord injury..
As a source of stem cells may advance fixing Spinal Cord TreatmentItalian and Spanish scientists, have the use of stem cells for the treatment of spinal cord injuries the first evidence that the meninges show the membrane that provided the central nervous system pelleted, a potential source of self-renewing stem cells. The research, published in STEM CELLS developed the understanding of cell activation in injuries of the central nervous system, promote research into new treatments for spinal cord injuries and degenerative brain diseases.A researcher at the Ohio State University Comprehensive Cancer Centers resulted which study, which was published in a recent issue of the journal Oncogene. – ‘The results are important because they to tell miRNAs miRNAs off genes that promote cancer,’says lead author Ramiro Garzon, a haematologist Oncologist at Ohio State James Cancer Hospital and Solove Research Institute.
The three be identified as miRNAs – 15b, miRNA-16-1 and let-7.. Next Read , they showed that the two miRNAs actually caused the loss of Bcl – 2 activity. They did it by providing additional quantities of each miRNA on leukemia cells not be treated with ATRA. Restoring miRNA causing a strong decrease in Bcl-2 level.
The study showed that ATRA increased the levels of said three definite miRNA into leukaemic cells and that this increase coincides with a decrease in the activity of two key cancer-causing antigens.